/주식/XCUR
XCUR

XCUR

USD

Exicure Inc. Common Stock

$10.800-0.632 (-5.526%)

실시간 가격

Healthcare
생명공학
미국

가격 차트

핵심 지표

시장 지표
기업 기본 정보
거래 통계

시장 지표

시가

$11.432

고가

$11.607

저가

$10.800

거래량

0.00M

기업 기본 정보

시가총액

70.3M

산업

생명공학

국가

United States

거래 통계

평균 거래량

0.03M

거래소

NCM

통화

USD

52주 범위

저가 $1.44현재가 $10.800고가 $36

관련 뉴스

BusinessWire

Exicure, Inc. (Nasdaq: XCUR) Nears Completion of Phase 2 Study of GPC-100 in Multiple Myeloma

Exicure, Inc. (NASDAQ:XCUR) today announced that GPCR Therapeutics USA, a subsidiary of Exicure Inc., has dosed the 19th patient in its ongoing Phase 2 clinical trial evaluating GPC-100 (burixafor), a small molecule

더 보기
Exicure, Inc. (Nasdaq: XCUR) Nears Completion of Phase 2 Study of GPC-100 in Multiple Myeloma
BusinessWire

Exicure, Inc. (Nasdaq: XCUR) Announces Their Next Step in Planning for a New Clinical Trial in Acute Myeloid Leukemia (AML)

Exicure, Inc. (NASDAQ:XCUR) today shared updates on its lead asset, GPC-100 (burixafor), a small molecule CXCR4 inhibitor. Exicure, Inc. ("Exicure") is planning for a clinical trial in Acute Myeloid Leukemia (AML) with

더 보기
Exicure, Inc. (Nasdaq: XCUR) Announces Their Next Step in Planning for a New Clinical Trial in Acute Myeloid Leukemia (AML)